Pelvic floor muscle function is an independent predictor of outcome after retrourethral transobturator male sling procedure

Soljanik, Irina; Bauer, Ricarda M.; Stief, Christian G.; Gozzi, Christian; Becker, Armin J.

doi:10.1007/s00345-014-1418-y

Cited by 6 publications

(4 citation statements)

References 26 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Until now, the studies did not prove significant progressive effectiveness in favor of the AdVance XP sling. Nevertheless, it emphasized advan-tages, for example, in the decrease of failure frequency in overweight participants [27,28]. A study comparing patients treated with either the AdVance sling or the Ad-Vance XP sling revealed a total cure rate of 77% following a median follow-up of 49 months [20,29].…”

Section: Discussionmentioning

confidence: 99%

Five-Year Results of a Prospective Multicenter Trial: AdVance XP for Postprostatectomy-Incontinence in Patients with Favorable Prognostic Factors

Mumm¹,

Klehr²,

Rodler³

et al. 2021

Urol Int

Self Cite

View full text Add to dashboard Cite

Objective: The aim of this study was to assess the security, value, and efficacy of the second-generation AdVance male sling XP (Boston Scientific®), after implementation in 2010 with advantageous modifications in the sling structure and needle shape, in a prospective multicenter long-term follow-up study. Methods: In total, 115 patients were included. Exclusion criteria were earlier incontinence (UI) surgery, nocturnal UI, former radiotherapy, or night-time incontinence. We also excluded patients with a functional urethra <1 cm in a preoperatively performed repositioning test. A consistent 24-h pad test, International Quality of Life (IQOL) score, visual analog pain scale (VAS), International Consultation-Incontinence Questionnaire (ICIQ-UI SF), International Index of Erectile Function (IIEF-5), International Prostate Symptom Score (IPSS), and Patient Global Impression of Improvement (PGI-I) scores were requested postoperatively. Results: The 24-month follow-up (114 patients) revealed 64.0% cured and 28.8% improved patients. Mean urine loss was reduced significantly to 19.0 g (p < 0.001). A mean PGI score of 1.5 and a mean VAS score of 0.2 were obtained. The 60-month follow-up (59 patients) revealed 57.6% cured and 25.4% improved patients. Mean urine loss was reduced significantly to 18.3 g (p < 0.001). A mean PGI score of 1.6 and a mean VAS score of 0.2 were obtained. Conclusions: The AdVance XP displays excellent continence results and secure effectiveness over a 5-year period. Moreover, these data are demonstrating low complication rates and improved quality of life in the long-term use of AdVance XP.

show abstract

Section: Discussionmentioning

confidence: 99%

Five-Year Results of a Prospective Multicenter Trial: AdVance XP for Postprostatectomy-Incontinence in Patients with Favorable Prognostic Factors

Mumm¹,

Klehr²,

Rodler³

et al. 2021

Urol Int

Self Cite

View full text Add to dashboard Cite

show abstract

“…However, the ICIQ-UI SF and OABSS will also be used as subjective measures to investigate UI symptoms and QoL. The status of pelvic floor muscles is closely related to urinary incontinence symptoms, and its electrical activity is widely used to reflect objective muscle contraction abilities [ 12 , 40 ]. Thus, both subjective and objective data regarding bladder function and QoL will be collected using self-reported questionnaires.…”

Section: Discussionmentioning

confidence: 99%

“…A probe will be inserted into the correct place of the vaginal (for females) or rectal (for males) region, and the PFM activity at rest will be recorded for 30 s, followed by two 5-s maximum voluntary contractions (MVCs) with a break of 15 s in between. The sEMG activity onset threshold will be considered the mean plus two standard deviations of the filtered and rectified EMG during the 30 s rest according to Baur et al [ 40 ]. The sEMG outcomes will be calculated as root mean square (RMS) values within the respective time intervals and averaged over 10 s.…”

Section: Methodsmentioning

confidence: 99%

Effectiveness of repetitive transcranial magnetic stimulation against poststroke urinary incontinence: a study protocol for a randomized controlled trial

Jiang

Tang

Song

et al. 2022

Trials

View full text Add to dashboard Cite

Background and purpose Poststroke urinary incontinence (PSI) is prevalent in stroke survivors, and high-quality evidence is required to guide clinical practice. Previous studies have demonstrated the curative effect of repetitive transcranial magnetic stimulation (rTMS) for urinary incontinence in individuals with multiple sclerosis (MS), Parkinson’s disease (PD), and spinal cord injury (SCI). Here, we describe the protocol for a randomized controlled trial to evaluate the efficacy and safety of low-frequency rTMS on the contralesional primary motor cortex (M1) for the treatment of PSI. Methods and analysis In this single-centre randomized controlled trial for poststroke urinary incontinence, a total of 140 eligible patients will be randomly allocated into two groups. The rTMS group (n = 70) will receive low-frequency rTMS at the M1 along with routine medical care, while the control group will receive sham rTMS along with routine medical care. All participants will undergo 20 treatment sessions, five times a week for 4 weeks. The primary outcome measures will be the changes in the urodynamic test at baseline versus 4 weeks after intervention. The secondary outcomes include the International Consultation on Incontinence Questionnaire Urinary Incontinence Short Form (ICIQ-UI SF), Overactive Bladder Symptom Score (OABSS), and pelvic floor muscle function. Ethics and dissemination The Institutional Review Board and Hospital Research Ethics Committee of the Second Affiliated Hospital of Chongqing Medical University approved this trial, and the approval number is No. 2020-153. All methods will be carried out in accordance with the principles of the Declaration of Helsinki and relevant ethical guidelines covering informed consent, confidentiality, and data storage. After the study had been thoroughly described to the participants by a physician, all participants will provide written informed consent indicating their willingness to participate. The results will be disseminated to most of the population, including participants, researchers, healthcare providers, and sponsors. Trial registration URL: https://www.chictr.org.cn; Unique identifier: ChiCTR2100042688. Date of Registration: 2021-01-26.

show abstract

“…From those findings, PFM functions can be measured by using the manometer positioned in healthy men. Although previous studies have assessed PFM strength with a manometer or the Oxford scale after prostatectomy, 18,19 to the best of our knowledge, the reliability of PFM function assessments in men has not been addressed. The present study showed that manometry is a reliable tool to evaluate PFM function in healthy men.…”

Section: Discussionmentioning

confidence: 99%

Reliability of manometry for assessing pelvic floor muscle function in healthy men

Ouchi

Kitta

Takahashi

et al. 2020

Neurourology and Urodynamics

View full text Add to dashboard Cite

Objectives To the best of our knowledge, no study has examined the reliability of assessment methods for male pelvic floor muscle (PFM) function. Therefore, this study aimed to clarify the reliability of manometry with an anal sensor (Peritron cat 9300A) to assess PFM function in healthy men. Methods Healthy male subjects (n = 21) without urinary leakage underwent testing to assess PFM function, and intra‐ and interrater reliability tests among examiners were performed. The PFM function included maximal anorectal squeeze pressure, endurance, mean anorectal squeeze pressure, gradient, and area under the curve during PFM voluntary contraction. Results Participants had a median age of 38 years (range 26‐51), and a mean BMI of 23.2 ± 2.0 kg/m2. Satisfactory intra‐ and interrater reliability scores were found for resting pressure, anorectal squeeze pressure, and endurance. The intra‐rater reliability of resting pressure, anorectal squeeze pressure, and endurance were 0.71, 0.89, and 0.75 for examiner 1 and 0.72, 0.89, and 0.87 for examiner 2. The interrater reliability for resting pressure, anorectal squeeze pressure, and endurance were 0.58, 0.93, and 0.61, respectively. Conclusions This is the first prospective study showing the favorable intra‐ and interrater reliability of manometry for PFM function in healthy men. Our findings demonstrated that manometry can provide both reliable and reproducible data regarding PFM function in continent men, suggesting Peritron cat 9300A can be used to evaluate the PFM function in men.

show abstract

Pelvic floor muscle function is an independent predictor of outcome after retrourethral transobturator male sling procedure

Abstract: PFMF improved significantly after RTS procedure. Higher muscle fatigue and weak PFMF were independent predictors of RTS failure. Digital rectal evaluation of PFMF is a simple and reliable clinical tool, which can be used by urologists in daily routine to predict the RTS outcome.

Cited by 6 publications

References 26 publications

Five-Year Results of a Prospective Multicenter Trial: AdVance XP for Postprostatectomy-Incontinence in Patients with Favorable Prognostic Factors

Five-Year Results of a Prospective Multicenter Trial: AdVance XP for Postprostatectomy-Incontinence in Patients with Favorable Prognostic Factors

Effectiveness of repetitive transcranial magnetic stimulation against poststroke urinary incontinence: a study protocol for a randomized controlled trial

Reliability of manometry for assessing pelvic floor muscle function in healthy men

Contact Info

Product

Resources

About